EndoMed Thoracic Stent Graft Requires Separate IDE – FDA Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
EndoMed envisions a late summer European launch for its pre-loaded aortomonoiliac and thoracic Endofit endoluminal stent grafts
You may also be interested in...
Medtronic Tests Talent For U.S. Thoracic Aortic Aneurysm Market
Medtronic is projecting that its Talent thoracic aortic aneurysm (TAA) endovascular stent graft system will gain premarket approval in late 2005
Medtronic Tests Talent For U.S. Thoracic Aortic Aneurysm Market
Medtronic is projecting that its Talent thoracic aortic aneurysm (TAA) endovascular stent graft system will gain premarket approval in late 2005
Endomed Plans To Re-Launch AAA Device In Europe, Following MDA Alert
Patient deaths related to Endomed, Inc.'s Endofit endoluminal aortic stent graft resulted from errors made by physicians who did not follow device instructions, the Phoenix-based company maintains